Literature DB >> 5712003

[Clinical experiences with the tuberculostatic drug capreomycin].

H Kollmeier, E Winkler, H Voss, M Ilgner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5712003

Source DB:  PubMed          Journal:  Beitr Klin Erforsch Tuberk Lungenkr        ISSN: 0300-9696


× No keyword cloud information.
  14 in total

1.  [BLIND LIVER BIOPSY AS A RELIABLE MEANS FOR EARLY DIAGNOSIS OF MILITARY TUBERCULOSIS].

Authors:  K BRUNNER; U P HAEMMERLI
Journal:  Dtsch Med Wochenschr       Date:  1964-04-03       Impact factor: 0.628

2.  STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.

Authors:  Y KOSEKI; S OKAMOTO
Journal:  Jpn J Med Sci Biol       Date:  1963-02

3.  [ON THE PROBLEM OF ANTIMYCOBACTERIAL EFFECT AND CROSS RESISTANCE OF CAPREOMYCIN].

Authors:  L TRNKA; J KUSKA; A HAVEL
Journal:  Prax Pneumol       Date:  1964-12

4.  [Iatrogenic jaundice].

Authors:  W SIEDE
Journal:  Internist (Berl)       Date:  1962-08       Impact factor: 0.743

5.  [On liver changes caused by tuberculosis].

Authors:  E KUNTZ
Journal:  Beitr Klin Tuberk Spezif Tuberkuloseforsch       Date:  1960

6.  Tuberculous hepatitis; report of a case with review of the literature.

Authors:  J GOLD; A WIGDERSON; E LEHMAN; I R SCHWARTZ
Journal:  Gastroenterology       Date:  1957-07       Impact factor: 22.682

7.  Capreomycin in the treatment of pulmonary tuberculosis.

Authors:  I Donomae
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

8.  The toxicity of capreomycin in laboratory animals.

Authors:  J S Welles; P N Harris; R M Small; H M Worth; R C Anderson
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

9.  Toxicology studies in patients on prolonged therapy with capreomycin.

Authors:  J D Miller; A G Popplewell; A Landwehr; M E Greene
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

10.  [On the so-called granulomatous hepatitis].

Authors:  J Eisenburg
Journal:  Dtsch Med Wochenschr       Date:  1967-04-21       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.